McAllan v National Prescribing Service trading as NPS Medicinewise

The applicant, McAllan, brought proceedings against the respondent, National Prescribing Service trading as NPS Medicinewise, in the Federal Court of Australia. The dispute concerned allegations of misleading and deceptive conduct in contravention of the *Australian Consumer Law* (ACL), specifically in relation to information provided by the respondent about a particular medication.

The primary legal issue before the Court was whether the respondent had engaged in conduct that was misleading or deceptive, or likely to mislead or deceive, in its dissemination of information concerning the medication. This involved an assessment of the nature of the information provided, the context in which it was presented, and the likely impact on the target audience, which included healthcare professionals and consumers.

Judge Barnes found that the respondent's conduct did not contravene the ACL. The Court reasoned that the information provided by NPS Medicinewise, when considered in its entirety and in the context of its intended audience, was not misleading or deceptive. The Court applied the established legal principles for assessing misleading or deceptive conduct under the ACL, focusing on whether the information created a false impression in the mind of the reasonable consumer or member of the target audience. The Court concluded that the information was presented in a manner that was balanced and sufficiently qualified, and therefore did not mislead or deceive.